All Oncology News

The OncLive® News page includes the latest in clinical oncology news, including breaking regulatory decisions, clinical trial findings, pivotal and practice-changing data published in academic peer-reviewed journals, and more across solid and hematologic malignancies. Regulatory news includes new drug approvals by the FDA and European Union, priority review and breakthrough therapy designations, and orphan drug and fast track statuses.

The Reality of End-of-Life Care

July 9th 2012

Much remains to be done in the USA to improve the care of patients at end-of-life.

Cetuximab Fails to Extend PFS in Advanced Gastric Cancer

July 5th 2012

The phase III EXPAND trial of cetuximab in combination with standard chemotherapy for patients with advanced gastric adenocarcinoma failed to show a significant improvement in progression-free survival.

Case-Based Discussion: Sequencing Prostate Cancer Therapy

July 3rd 2012

Case-based discussion on sequencing prostate cancer therapies for a 72-year-old man with a metastatic adenocarcinoma with small-cell components, a PSA score of 80, and a Gleason score of 10.

Oncology Leaders Praise Health Law Ruling-With Caveats

June 28th 2012

Leaders in the oncology care and research communities largely applauded the US Supreme Court ruling Thursday that upholds the Affordable Care Act.

Nursing Shortage or Shortage of Nursing Care?

June 25th 2012

Recent survey suggests it's a shortage of care, not nurses.

ODAC Supports Carfilzomib for Relapsed Multiple Myeloma

June 20th 2012

ODAC voted 11-0 in support of carfilzomib as a new treatment option for patients with multiple myeloma, despite side effect concerns raised by the FDA.

Health Insurance Gaps

June 20th 2012

2011 survey finds 25% of adults experienced a gap in health insurance last year.

Sensational Medical Reporting

June 13th 2012

Is the list of "10 shocking medical mistakes" informational or just sensational?

Pertuzumab Gains Approval as Dual Anti-HER2 Breast Cancer Treatment

June 11th 2012

The FDA has approved pertuzumab combined with trastuzumab and docetaxel for patients who have not received prior treatment for HER2-positive metastatic breast cancer.

NSAIDs for Skin Cancer Prevention

May 31st 2012

Researchers find that people who took NSAIDs were less likely to develop skin cancer.

CDX-011 Shows Promise in GPNMB-Positive Triple-Negative Breast Cancer

May 23rd 2012

CDX-011, a targeted therapy designed to treat patients with advanced breast cancer, appears to increase PFS in TNBC patients who have received multiple prior lines of therapy and express GPNMB.

Federal Panel Rejects Routine Prostate Cancer Screening

May 22nd 2012

The USPSTF has made a final recommendation against routine screening for prostate cancer in asymptomatic males through PSA testing.

Celldex Announces Webcast of EMERGE Data

May 21st 2012

Celldex Therapeutics will present the interim results of a phase IIb study testing the efficacy of a new monoclonal antibody in patients with advanced breast cancer.

Sugar Fueled Diets

May 21st 2012

Is it helpful to add omega-3 fatty acids to minimize the damage?

UK Advisory Group Reverses Decision on Abiraterone; Drug Expected to Be Funded

May 18th 2012

The prostate cancer drug abiraterone acetate is expected be provided for patients through England's publicly funded healthcare system after NICE reversed its initial recommendation.

Healthcare Spending

May 9th 2012

Japan spends the least on healthcare and the US spends the most--without providing superior care for the money.

Pass the Carrots Please

May 1st 2012

Costs associated with obesity are even higher than originally thought.

Pazopanib Receives FDA Approval for Treatment of Soft Tissue Sarcoma

April 27th 2012

The FDA has approved pazopanib for the treatment of patients with advanced soft tissue sarcoma who have previously received chemotherapy.

Landmark Study Redefines Breast Cancer Into 10 Subtypes

April 25th 2012

Researchers have determined that breast cancer can be classified into 10 different subtypes instead of four subtypes as previously thought.

Nurses Needed for the Nurses' Health Study

April 23rd 2012

Landmark study seeks 100,000 new participants.